ZECUITY Drug Patent Profile

✉ Email this page to a colleague

When do Zecuity patents expire, and what generic alternatives are available?

Zecuity is a drug marketed by Teva Branded Pharm and is included in one NDA. There are nine patents protecting this drug.

This drug has ninety-two patent family members in fourteen countries.

The generic ingredient in ZECUITY is sumatriptan succinate. There are twenty-four drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the sumatriptan succinate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Zecuity

A generic version of ZECUITY was approved as sumatriptan succinate by WEST-WARD PHARMS INT on February 6^th, 2009.

Try a Trial

Summary for ZECUITY

International Patents:	92
US Patents:	9
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	70
Clinical Trials:	1
Patent Applications:	5,500
Formulation / Manufacturing:	see details
DailyMed Link:	ZECUITY at DailyMed

Drug patent expirations by year for ZECUITY

Recent Clinical Trials for ZECUITY

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
NuPathe Inc.	Phase 1

See all ZECUITY clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for ZECUITY

N02CC	Selective serotonin (5HT1) agonists
N02C	ANTIMIGRAINE PREPARATIONS
N02	ANALGESICS
N	Nervous system

US Patents and Regulatory Information for ZECUITY

ZECUITY is protected by nine US patents.

Patents protecting ZECUITY

Transdermal methods and systems for the delivery of anti-migraine compounds
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: METHOD FOR TREATING ACUTE MIGRAINE IN ADULTS, WITH OR WITHOUT AURA,COMPRISING IONTOPHORETIC TRANSDERMAL DELIVERY OF SUMATRIPTAN OR A SALT THEREOF

Pharmacokinetics of iontophoretic sumatriptan administration
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: METHOD FOR TREATING ACUTE MIGRAINE IN ADULTS, WITH OR WITHOUT AURA,COMPRISING IONTOPHORETIC TRANSDERMAL DELIVERY OF SUMATRIPTAN OR A SALT THEREOF

Polyamine enhanced formulations for triptan compound iontophoresis
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: METHOD FOR TREATING ACUTE MIGRAINE IN ADULTS, WITH OR WITHOUT AURA, COMPRISING IONTOPHORETIC TRANSDERMAL DELIVERY OF SUMATRIPTAN OR A SALT THEREOF, USING A FLOWABLE HYDROGEL FORMULATION

Pharmacokinetics of iontophoretic sumatriptan administration
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial

Electronic control of drug delivery system
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: METHOD FOR TREATING ACUTE MIGRAINE IN ADULTS, WITH OR WITHOUT AURA,COMPRISING IONTOPHORETIC TRANSDERMAL DELIVERY OF SUMATRIPTAN OR A SALT THEREOF

Transdermal methods and systems for the delivery of anti-migraine compounds
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial

User-activated self-contained co-packaged iontophoretic drug delivery system
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: METHOD FOR TREATING ACUTE MIGRAINE IN ADULTS, WITH OR WITHOUT AURA,COMPRISING IONTOPHORETIC TRANSDERMAL DELIVERY OF SUMATRIPTAN OR A SALT THEREOF

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Teva Branded Pharm	ZECUITY	sumatriptan succinate	SYSTEM;IONTOPHORESIS	202278-001	Jan 17, 2013		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Teva Branded Pharm	ZECUITY	sumatriptan succinate	SYSTEM;IONTOPHORESIS	202278-001	Jan 17, 2013		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial	Y			⤷ Try a Trial
Teva Branded Pharm	ZECUITY	sumatriptan succinate	SYSTEM;IONTOPHORESIS	202278-001	Jan 17, 2013		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Teva Branded Pharm	ZECUITY	sumatriptan succinate	SYSTEM;IONTOPHORESIS	202278-001	Jan 17, 2013		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial	Y			⤷ Try a Trial
Teva Branded Pharm	ZECUITY	sumatriptan succinate	SYSTEM;IONTOPHORESIS	202278-001	Jan 17, 2013		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for ZECUITY

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Teva Branded Pharm	ZECUITY	sumatriptan succinate	SYSTEM;IONTOPHORESIS	202278-001	Jan 17, 2013	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for ZECUITY

See the table below for patents covering ZECUITY around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
Australia	2015224400	Polyamine enhanced formulations for triptan compound iontophoresis	⤷ Try a Trial
Eurasian Patent Organization	201100056	ФАРМАКОКИНЕТИКА СУМАТРИПТАНА, ВВОДИМОГО МЕТОДОМ ИОНТОФОРЕЗА	⤷ Try a Trial
Eurasian Patent Organization	023339	УСИЛЕННЫЕ ПОЛИАМИНОМ СОСТАВЫ ДЛЯ ИОНТОФОРЕЗА СОЕДИНЕНИЯ ТРИПТАНА (POLYAMINE ENHANCED FORMULATIONS FOR TRIPTAN COMPOUND IONTOPHORESIS)	⤷ Try a Trial
Eurasian Patent Organization	023147	ТРАНСДЕРМАЛЬНЫЙ ПЛАСТЫРЬ ДЛЯ ЛЕЧЕНИЯ МИГРЕНИ (TRANSDERMAL PATCH FOR TREATING MIGRAINE)	⤷ Try a Trial
Canada	2944660	REGULATION ELECTRONIQUE D'UN SYSTEME DE DISTRIBUTION DE MEDICAMENT (ELECTRONIC CONTROL OF DRUG DELIVERY SYSTEM)	⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Summary for ZECUITY

Recent Clinical Trials for ZECUITY

Anatomical Therapeutic Chemical (ATC) Classes for ZECUITY

Patents protecting ZECUITY

Make Better Decisions: Try a trial or see plans & pricing